BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26298539)

  • 1. Clozapine improves the orienting of attention in schizophrenia.
    Spagna A; Dong Y; Mackie MA; Li M; Harvey PD; Tian Y; Wang K; Fan J
    Schizophr Res; 2015 Oct; 168(1-2):285-91. PubMed ID: 26298539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients.
    Meiron O; Hermesh H; Katz N; Weizman A
    Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The executive control of attention differentiates patients with schizophrenia, their first-degree relatives and healthy controls.
    Breton F; Planté A; Legauffre C; Morel N; Adès J; Gorwood P; Ramoz N; Dubertret C
    Neuropsychologia; 2011 Jan; 49(2):203-8. PubMed ID: 21095198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preattentional processes and disorganization in schizophrenia: Influence of a 6-week risperidone treatment.
    Amado I; Bourdel MC; Daban C; Poirier MF; Loo H; Bouhours P; Krebs MO
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1107-12. PubMed ID: 19527763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation.
    Bosia M; Anselmetti S; Pirovano A; Ermoli E; Marino E; Bramanti P; Smeraldi E; Cavallaro R
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):81-5. PubMed ID: 19818823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
    Kaneda Y; Jayathilak K; Meltzer H
    Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunctional personality traits in adolescence: effects on alerting, orienting and executive control of attention.
    Casagrande M; Marotta A; Canepone V; Spagna A; Rosa C; Dimaggio G; Pasini A
    Cogn Process; 2017 May; 18(2):183-193. PubMed ID: 28285372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal attentional internetwork link in dyslexic readers.
    Goldfarb L; Shaul S
    Neuropsychology; 2013 Nov; 27(6):725-9. PubMed ID: 24040923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine treatment reduces the deficit of executive control of attention in patients with major depressive disorder.
    Tian Y; Du J; Spagna A; Mackie MA; Gu X; Dong Y; Fan J; Wang K
    Sci Rep; 2016 Jun; 6():28028. PubMed ID: 27306061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P300 alterations in schizophrenic patients experiencing auditory hallucinations.
    Papageorgiou C; Oulis P; Vasios C; Kontopantelis E; Uzunoglu N; Rabavilas A; Christodoulou GN
    Eur Neuropsychopharmacol; 2004 May; 14(3):227-36. PubMed ID: 15056482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disentangling the attentional deficit in schizophrenia: pointers from schizotypy.
    Le Pelley ME; Schmidt-Hansen M; Harris NJ; Lunter CM; Morris CS
    Psychiatry Res; 2010 Apr; 176(2-3):143-9. PubMed ID: 20138371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attentional impairments in Huntington's disease: A specific deficit for the executive conflict.
    Maurage P; Heeren A; Lahaye M; Jeanjean A; Guettat L; Verellen-Dumoulin C; Halkin S; Billieux J; Constant E
    Neuropsychology; 2017 May; 31(4):424-436. PubMed ID: 28240935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clozapine on cognitive function in schizophrenia.
    Lee MA; Thompson PA; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
    Woodward ND; Jayathilake K; Meltzer HY
    Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention networks in children with idiopathic generalized epilepsy.
    Tian Y; Dong B; Ma J; Zhou S; Zhou N; Wang K
    Epilepsy Behav; 2010 Nov; 19(3):513-7. PubMed ID: 20797914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sertindole on cognition in clozapine-treated schizophrenia patients.
    Nielsen RE; Levander S; Thode D; Nielsen J
    Acta Psychiatr Scand; 2012 Jul; 126(1):31-9. PubMed ID: 22356584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test-retest reliability of Attention Network Test measures in schizophrenia.
    Hahn E; Ta TM; Hahn C; Kuehl LK; Ruehl C; Neuhaus AH; Dettling M
    Schizophr Res; 2011 Dec; 133(1-3):218-22. PubMed ID: 22000937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients.
    Hori H; Yoshimura R; Katsuki A; Sugita AI; Atake K; Nakamura J
    J Psychiatr Res; 2013 Dec; 47(12):1843-8. PubMed ID: 24054464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia.
    Turner DC; Clark L; Pomarol-Clotet E; McKenna P; Robbins TW; Sahakian BJ
    Neuropsychopharmacology; 2004 Jul; 29(7):1363-73. PubMed ID: 15085092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia.
    Chudasama Y; Robbins TW
    Psychopharmacology (Berl); 2004 Jun; 174(1):86-98. PubMed ID: 15071717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.